Publicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (27)

2024

  1. Tumor-induced osteomalacia: A systematic literature review

    Bone Reports, Vol. 21

2020

  1. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: A multicentric matched cohort study

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 12, pp. 1544-1549

2016

  1. Cut-offs and response criteria for the Hospital Universitario la Princesa Index (HUPI) and their comparison to widely-used indices of disease activity in rheumatoid arthritis

    PLoS ONE, Vol. 11, Núm. 9

2015

  1. Lipid profile changes in patients with chronic inflammatory arthritis treated with biologic agents and tofacitinib in randomized clinical trials: A systematic review and meta-analysis

    Arthritis and Rheumatology, Vol. 67, Núm. 1, pp. 117-127

  2. Predictors of treatment failure and mortality in native septic arthritis

    Clinical Rheumatology, Vol. 34, Núm. 11, pp. 1961-1967

2014

  1. Documento práctico para el uso de abatacept subcutáneo

    Reumatologia Clinica, Vol. 10, Núm. 4, pp. 218-226

  2. Facteur rhumatoïde et réponse aux anti-TNF dans la polyarthrite rhumatoïde: revue systématique et méta-analyse d'études observationnelles

    Revue du Rhumatisme (Edition Francaise), Vol. 81, Núm. 1, pp. 58-68

  3. Observational study of optimization of biologic therapies in rheumatoid arthritis: A single-centre experience

    Rheumatology International, Vol. 34, Núm. 8, pp. 1059-1063

  4. Rheumatoid factor and response to TNF antagonists in rheumatoid arthritis: Systematic review and meta-analysis of observational studies

    Joint Bone Spine, Vol. 81, Núm. 1, pp. 41-50

  5. Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: A systematic review and meta-analysis of randomized controlled trials and long-term extension studies

    Rheumatology (United Kingdom), Vol. 53, Núm. 10, pp. 1872-1885

  6. Safety profile of protein kinase inhibitors in rheumatoid arthritis: Systematic review and meta-analysis

    Annals of the Rheumatic Diseases, Vol. 73, Núm. 5, pp. 871-882

2013

  1. Cutaneous adverse events during treatment of chronic inflammatory rheumatic conditions with tumor necrosis factor antagonists: Study using the spanish registry of adverse events of biological therapies in rheumatic diseases

    Arthritis Care and Research, Vol. 65, Núm. 12, pp. 2024-2031

  2. El uso de abatacept en artritis reumatoide: Revisión de la evidencia y recomendaciones

    Reumatologia Clinica, Vol. 9, Núm. 1, pp. 5-17

  3. Le facteur rhumatoïde ne semble pas prédire la réponse aux anti-TNF α dans la polyarthrite rhumatoïde: expérience de trois centres

    Revue du Rhumatisme (Edition Francaise)

  4. Rheumatoid factor does not predict response to TNF antagonists in rheumatoid arthritis: Three centers experience

    Joint Bone Spine

2012

  1. Change in the discontinuation pattern of tumour necrosis factor antagonists in rheumatoid arthritis over 10 years: Data from the Spanish registry BIOBADASER 2.0

    Annals of the Rheumatic Diseases, Vol. 71, Núm. 3, pp. 382-385

2011

  1. Consenso SER sobre la gestión de riesgo del tratamiento con terapias biológicas en pacientes con enfermedades reumáticas

    Reumatologia Clinica, Vol. 7, Núm. 5, pp. 284-298

  2. Infecciones en pacientes tratados con antagonistas del factor de necrosis tumoral: incidencia, etiología y mortalidad en el registro BIOBADASER

    Medicina Clinica, Vol. 137, Núm. 12, pp. 533-540

2010

  1. Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists

    Annals of the Rheumatic Diseases, Vol. 69, Núm. 10, pp. 1751-1755

  2. Recommendations for the management of influenza A (H1N1) in rheumatic patients with immunosuppression

    Reumatologia Clinica, Vol. 6, Núm. 1, pp. 63-68